Literature DB >> 19051286

Genetic and epigenetic analysis of SSAT gene dysregulation in suicidal behavior.

Michel Guipponi1, Samuel Deutsch, Karine Kohler, Nader Perroud, François Le Gal, Monique Vessaz, Térèse Laforge, Brice Petit, Fabrice Jollant, Sébastien Guillaume, Patrick Baud, Philippe Courtet, Romano La Harpe, Alain Malafosse.   

Abstract

It has recently been proposed that the SSAT gene plays a role in the predisposition to suicidal behavior. SSAT expression was found to be down-regulated in the brain of suicide completers. In addition, a single nucleotide polymorphism (SNP) rs6526342 was associated both with variation in SSAT expression and with suicidal behavior. In this study, we aimed to characterize the relationship between SSAT dysregulation and suicide behavior. To this end, we measured SSAT expression levels in the ventral prefrontal cortex (VPFC) of suicide completers (n = 20) and controls (n = 20) and found them to be significantly down-regulated in suicide victims (P = 0.007). To identify the basis of the regulation of SSAT expression, we performed an association analysis of 309 SNPs with SSAT transcript levels in 53 lymphoblastoid cell lines from the CEPH collection. We then examined the methylation status of the SSAT promoter region in males and females suicide completers and control subjects whose SSAT brain expression had been measured. We found no evidence to support a role for SNPs in controlling the level of SSAT expression. SSAT promoter methylation levels were not different between suicide completers and controls and did not correlate with SSAT expression levels. In addition, we found no indication of a genetic association between suicidal behavior and SNPs located within the SSAT gene. Our study provides new results which show that dysregulation of SSAT expression does play a role in suicide behavior. However, our data do not support any association between rs6526342 and variation in SSAT expression or suicidal behavior. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19051286     DOI: 10.1002/ajmg.b.30901

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  25 in total

Review 1.  Suicide and the polyamine system.

Authors:  Jeffrey A Gross; Gustavo Turecki
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-11       Impact factor: 4.388

Review 2.  Mammalian polyamine metabolism and function.

Authors:  Anthony E Pegg
Journal:  IUBMB Life       Date:  2009-09       Impact factor: 3.885

Review 3.  Suicidal ideation during antidepressant treatment: do genetic predictors exist?

Authors:  Nader Perroud
Journal:  CNS Drugs       Date:  2011-06-01       Impact factor: 5.749

Review 4.  Current status of the polyamine research field.

Authors:  Anthony E Pegg; Robert A Casero
Journal:  Methods Mol Biol       Date:  2011

5.  Evidence of altered polyamine concentrations in cerebral cortex of suicide completers.

Authors:  Gary Gang Chen; Laura M Fiori; Luc Moquin; Alain Gratton; Orval Mamer; Naguib Mechawar; Gustavo Turecki
Journal:  Neuropsychopharmacology       Date:  2010-03-03       Impact factor: 7.853

Review 6.  Targets of polyamine dysregulation in major depression and suicide: Activity-dependent feedback, excitability, and neurotransmission.

Authors:  Agenor Limon; Firoza Mamdani; Brooke E Hjelm; Marquis P Vawter; Adolfo Sequeira
Journal:  Neurosci Biobehav Rev       Date:  2016-04-22       Impact factor: 8.989

Review 7.  The molecular bases of the suicidal brain.

Authors:  Gustavo Turecki
Journal:  Nat Rev Neurosci       Date:  2014-10-30       Impact factor: 34.870

Review 8.  Sensitive periods in epigenetics: bringing us closer to complex behavioral phenotypes.

Authors:  Corina Nagy; Gustavo Turecki
Journal:  Epigenomics       Date:  2012-08       Impact factor: 4.778

9.  Epigenetics and suicidal behavior research pathways.

Authors:  Gustavo Turecki
Journal:  Am J Prev Med       Date:  2014-09       Impact factor: 5.043

10.  Association of polyaminergic loci with anxiety, mood disorders, and attempted suicide.

Authors:  Laura M Fiori; Brigitte Wanner; Valérie Jomphe; Jordie Croteau; Frank Vitaro; Richard E Tremblay; Alexandre Bureau; Gustavo Turecki
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.